Fisher & Paykel Healthcare Corporation Limited (FPH.AX)

24,37 -0,23 (-0,93%) Alla chiusura: 04:10PM AEST

Fisher & Paykel Healthcare Corporation Limited

15 Maurice Paykel Place
East Tamaki
Auckland 2013
New Zealand
64 9 574 0100
https://www.fphcare.com

Settore/i: Healthcare
Settore: Medical Instruments & Supplies
Impiegati a tempo pieno: 6.391

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Lewis G. Gradon	MD, CEO & Executive Director	2,35M	N/D	1961
Ms. Lyndal York	Chief Financial Officer	N/D	N/D	N/D
Andy Niccol	COO & GM of Respiratory Humidification	N/D	N/D	N/D
Dr. Andrew Somervell	Vice President of Products & Technology	N/D	N/D	N/D
Hayden Brown	Head of Capital Markets & Investor Relations	N/D	N/D	N/D
Raelene Leonard	Company Secretary & General Counsel	N/D	N/D	N/D
Daniel Adolph	Senior Communications & Investor Relations Manager	N/D	N/D	N/D
Mr. Justin Callahan	VP of Sales & Marketing and President of North America & Europe	N/D	N/D	N/D
Ms. Nicola Talbot	Vice President of Human Resources	N/D	N/D	N/D
Mr. Jonathan Rhodes	Vice President of Supply Chain, Facilities & Sustainability	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in AUD.

Descrizione

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Governance aziendale

L'ISS Governance QualityScore di Fisher & Paykel Healthcare Corporation Limited al 1 aprile 2024 è 6. I criteri di valutazione fondamentali sono revisione: 5; Consiglio di Amministrazione: 5; diritti degli azionisti: 7; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.